ADALIMUMAB
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices
ADALIMUMAB (12328W)
12328W
Manner of administration:Injection
Restriction (Streamlined authority code: 14683)
Indication: Ankylosing spondylitis
Treatment phase: First continuing treatment
Restriction (Streamlined authority code: 14701)
Indication: Ankylosing spondylitis
Treatment phase: Subsequent continuing treatment
